Skip to main content
. Author manuscript; available in PMC: 2010 Oct 22.
Published in final edited form as: Arch Surg. 1980 Jul;115(7):815–819. doi: 10.1001/archsurg.1980.01380070009002

Table 1.

Consecutive Recent Orthotopic Liver Transplantations (OT)
OT NO. Diagnosis Donor/Recipient Age, yr Ischemia Time, hr, min Survival, Days Last Bilirubin, Level, mg/dL Cause of Death, Clinical and Autopsy Graft Histopathology
141 Chronic aggressive hepatitis, hepatitis B surface antigen positive (HBsAg +) 17/31 2,46 355 28 Liver failure from chronic rejection and recurrent hepatitis End-stage chronic rejection; Biopsy (bx,) results at 147 and 179 days had shown progressing rejection; no evidence of recurrent hepatitis B infection
142 Alpha1-antitrypsin deficiency (with hepatoblastoma) 3½/5 3,42 612 0.8 Alive Bx results at 166 days and 1 yr, 57 days showed continuing low-grade rejection
143 Sclerosing cholangitis 17/31 1,45 386 16 Intraabdominal infection; liver failure from chronic rejection; and (?) cholangitis Diffuse fatty change and some centrilobular necrosis; no evidence of rejection or sclerosing cholangitis
144 Alcoholic cirrhosis (previous shunt) 19/39 6,15 563 0.8 Alive No bx
145 Chronic aggressive hepatitis (previous shunt) 15/22 7,18 20 16 Acute liver failure from ischemic graft injury; candidiasis No ischemic injury in bx results at 14 days, only evidence of biliary obstruction; same at autopsy
146 Primary biliary cirrhosis 21/49 1,23 502 0.8 Alive Bx results at 30 and 111 days showed cellular rejection; no evidence of hepatitis despite being HBsAg +
147 Biliary atresia 2½/5½ 7,26 42 3.7 Peritonitis from enteric fistula; candidiasis Diffuse fatty change; multiple small foci of Candida infection
148 Chronic aggressive hepatitis (a)13/29
(b)18/29
1,17
1,29
16 34 Acute liver failure from (?) ischemic graft injury, 1st graft; Gram-negative septicemia, 2nd graft (a) Acute cellular rejection; (b)Fatty change and some cholestasis in centrilobular hepatocytes ____
149 Sclerosing cholangitis 18/38 1,34 80 10.6 Peritonitis and persistent duodenal fistula; pneumonitis Centrilobular fatty Change; arteriolar narrowing from past rejection ____
150 Biliary cirrhosis (secondary to trauma) 7/15 2,2 472 0.8 Alive Bx result at 33 days showed acute cellular rejection
151 Biliary atresia (previous Kasai procedure) 2/5 8,51 72 3.3 Chicken pox; fresh portal thrombosis Herpes group viruses seen by electron microscopy in necrotic tissue and in some of adjacent cells
152 Biliary cirrhosis (secondary to choledochocyst) 1½/29 2,5 19 8.3 Peritonitis from enteric fistulas; questionable candidiasis; no autopsy No bx or autopsy
153 Chronic aggressive hepatitis 16/28 2,30 21 1.8 Acute hemorrhage from esophageal varices* Some atrophy of hepatocytes because of lack of portal blood; no evidence of rejection
154 Alpha1-antitrypsin deficiency 4/6 8,23 54 11 Liver failure with intrahepatic arterial thrombosis; regional liver infarctions and Gram-negative septicemia Intrahepatic arterial thromboses and infarcts in bx results at 29 days and at autopsy; no evidence of rejection in surviving liver; (?) primary thrombosis due to endothelial damage caused by eight hr ischemia .
155 Alpha1-antitrypsin deficiency 8/11 1,24 395 0.5 Alive Bx result at six mo showed acute cellular rejection
156 Chronic aggressive hepatitis (a) 8/24
(b) 24/34
7,20
5,23
194 6 Acute liver failure from Ischemic injury, 1st graft; arterial thrombosis, 2nd graft, neurologic invalidism (a) Cholangitis, centrilobular cholestasis and marked centrilobular and midzonal fatty change; did not look like Simple ischemic damage
(b) Bx results at 69 and 124 days showed acute and chronic rejection, respectively, with arterial involvement; at autopsy at 179 days there were multiple large areas of old and recent ischemic necrosis and atrophy of hepatocytes caused by arterial lesions of chronic rejection
157 Chronic aggressive hepatitis 19/21 2,10 120 35 Liver failure from portal thrombosis and (?) chronic rejection Bx results at 14, 62 and 109 days showed progression from acute cellular rejection to chronic rejection with narrowing and obliteration of intrahepatic artery branches and portal vein tributaries; at autopsy large areas of hemorrhagic necrosis from recent main portal vein thrombosis predominated
158 Congenital hepatic fibrosis 2/2 1,45 21 15.4 Acute rejection Acute cellular rejection with necrosis of centrilobular and midzonal hepatocytes
159 Alpha1-antitrypsin deficiency 3/9 7,39 56 0.8 Pulmonary emboli Little fat in hepatocytes; mild mononuclear cell infiltration of portal tract
160 Protoporphyria 9/21 8 26 10.8 Cardiac insufficiency; candidiasis Fatty change and some cholestasis
161 Biliary atresia (previous Kasai procedure) 1/2 7,12 28 1.1 (?) Adenovirus hepatitis; Gram-negative septicemia Bx results at 16 days showed acute cellular rejection; no autopsy tissue available
162 Biliary atresia (previous Kasai procedure) 1/2½ 6,26 5 3.4 Respiratory insufficiency from oversized graft Focal areas of centrilobular and midzonal hemorrhagic necrosis; fatty change, cell cholestasis and moderately dense mononuclear cell infiltration of portal tracts
163 Biliary atresia 1½/3 1,23 30 2.6 (?) Adenovirus hepatitis Multiple focal areas of necrosis; some of these contain large candida colonies; nuclear inclusions in the hepatocytes bordering the necrotic foci; by electron microscopy these are found to consist of adenovirus particles
*

At operation, portal cavernous transformation found. Graft portal vein anastomosed to vena caval which subsequently clotted.

Last SGOT values more than 2,000 IU/L.